MAP1LC3A and lung carcinoma: Herein, we found that knockdown of USP24 by shUSP24 or targeting USP24 by the USP24 inhibitor USP24-i in A549-T24 and PC9-GR drug-resistant lung cancer cell lines increased the LC3 levels but decreased the E2F4 levels (Fig. 2C, D).